Semaglutide is a potent, long-acting GLP-1 receptor agonist. It affects cAMP/PKA, AMPK, and mTOR signaling pathways, by binding to GLP-1R and increasing intracellular cAMP, promoting insulin secretion and autophagy, and inhibiting oxidative stress, inflammation, and apoptosis.